Synthesis and cytotoxicity of platinum(II) complexes of a physiologically active carrier histamine

Archiv der Pharmazie

Volumn 341, Issue 2, 2008, Pages 132-136

  Chen, Xi Zhu ^a   Ye, Qing Song ^a   Lou, Li Guang ^b   Xie, Ming Jin ^a   Liu, Wei Ping ^a   Yu, Yao ^a   Hou, Shu Qian ^a  

^a KUNMING INSTITUTE OF PRECIOUS METALS   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Antitumor activity; Histamine; Platinum(II) complexes; Structure; Synthesis

Indexed keywords

1,1 CYCLOBUTANEDICARBOXYLIC ACID; 3 HYDROXY 1,1 CYCLOBUTANEDICARBOXYLATE; CARBOPLATIN; CISPLATIN; HISTAMINE; MALONIC ACID; OXALIC ACID; PLATINUM COMPLEX; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CHELATING AGENT; CIS (PT(HISTAMINE)CL2); CIS-(PT(HISTAMINE)CL2); DRUG DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL LINE; CELL STRAIN LNCAP; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELEMENTAL ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SPECTROSCOPY; TECHNIQUE; X RAY CRYSTALLOGRAPHY; CHEMISTRY; DRUG RESISTANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHELATING AGENTS; CRYSTALLOGRAPHY, X-RAY; DRUG RESISTANCE, NEOPLASM; HISTAMINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; ORGANOPLATINUM COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 43149121821     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200700155     Document Type: Article

References (29)

1. P. Loehrer, I. Einhorn, Ann. Intern. Med. 1984, 100, 704-713.
2. E. Wong, C. M. Giandomenico, Chem. Rev. 1999, 99, 2451-2466.
3. M. Kartalou, J. M. Essigmann, Mutat. Res. 2001, 478, 1-21.
4. Z. Siddik, Oncogene 2003, 22, 7265-7279.
5. Z. Guo, P. J. Sadler, Angew. Chem. Int. Ed. 1999, 38, 1512-1531.
6. Y. P. Ho, S. C. F. Au-Yeung, K. K. W. To, Med. Res. Rev. 2003, 23, 633-655.
7. M. A. Jakupec, M. Galanski, B. K. Keppler, Rev. Physiol. Biochem. Pharmacol. 2003, 146, 1-53.
8. K. Irena, Recent Patents on Anti - cancer Drugs Discovery 2006, 1, 1-22.
9. G. Momekov, A. Bakalova, M. Karaivanova, Curr. Med. Chem. 2005, 12, 2177-2191.
10. S. V. Zutphen, J. Reedijk, Coord. Chem. Rev. 2005, 249, 2845-2853.
11. M. Galanski, V. B. Arion, M. A. Jakupec, B. K. Keppler, Current Pharm. Design 2003, 9, 2078-2089.
12. K. Daniel, N. Emilya, P. Julita, M. Liliana, et al., Z. Naturforsch. 2003, 58C, 103-108.
13. L. Wang, S. Gou, Y. Chen, Y. Liu, Bioorg. Med. Chem. Lett. 2005, 15, 3417-3422.
14. C. W. Yu, K. K. W. Li, S. K. Pang, S. C. F. Au-Yeung, Y. P. Ho, Bioorg. Med. Chem. Lett. 2006, 16, 1686-1691.
15. L. Duan, Pharmacology, The People's Health Publishing Company, 1999, p. 239.
16. D. D. Perrin, I. G. Sayce, V. S. Sharma, J. Chem. Soc. (A), Inorg. Phys. Theor. 1967, 1755-1759.
17. D. D. Perrin, I. G. Sayce, V. S. Sharma, J. Chem. Soc. (A), Inorg. Phys. Theor. 1968, 446-448.
18. D. D. Perrin, I. G. Sayce, V. S. Sharma, J. Chem. Soc. (A), Inorg. Phys. Theor. 1969, 2060-2062.
19. P. Garnuszek, J. K. Maurin, J. Witowska-Jarosz, B. Ptasiewicz-Bak, Inorg. Chim. Acta. 2002, 338, 119-126.
20. S. C. Dehra, Indian J. Chem. 1970, 8, 191-194.
21. M. J. Clare, J. D. Hoeschele, Platinum Metals Rev. 1973, 17, 2-13.
22. E. J. Lee, M. J. Jun, Y. S. Sohn, Bull. Korean Chem. Soc. 1999, 20, 1469-1474.
23. T. Mosmann, J. Immunol. Method 1983, 65, 55-63.
24. K. J. Mellish, L. R. Kelland, K. R. Harrap, Br. J. Cancer 1993, 68, 240-250.
25. X. Chen, M. Xie, W. Liu, Q. Ye, Inorg. Chim. Acta. 2007, 360, 2851-2856.
26. A. Pasini, F. Zunino, Angew. Chem. Int. Ed. 1997, 26, 615-624.
27. G. W. Sheldrick, SHELXS-97, Program for Crystal Structure Solution, University of Göttingen, Germany, 1997.
28. G. W. Sheldrick, SHELXS-97, Program for Crystal Structure Refinement, University of Göttingen, Germany, 1997.
29. C. K. Johnson, Report ORNL-5138, OAK Ridge National Laboratory, OAK Ridge, TN, 1976.